Closing soon

Stability Testing for ManNAc Drug Product produced in Campaigns 5 and 6. Stability testing will occur under regulatory compliance RFP

Description: This active presolicitation is an NIH notice of intent to award a noncompetitive contract for regulatory stability testing of ManNAc drug product from Campaigns 5 and 6. NHGRI took over the required stability-testing program for 48 kg of donated clinical-grade product previously tested by Alcami Corporation, which is intended for upcoming clinical trials. Interested parties may submit capability and proposal information by November 9, 2026 at 9:00 AM Eastern; the notice is not a request for competitive proposals.

Buyer
Released
Oct 28, 2026
Closes
Nov 9, 2026(1 days left)
See your top accountsScan your site in seconds. Starbridge identifies your ICP and surfaces emerging opportunities from board meetings, job changes, new grants, contract expirations, RFPs, and more.
See your top 10 accounts